Home/Protocols/Pigmentation & Melasma/TXA-sr
New

prodermic TXA.sr

Tranexamic Serum
SKU TXA · 30ml · Serum
1,498
MRP 2,995
~75 sessions per jar
50% Expert Discount

Prodermic TXA.sr is a premium melasma maintenance serum that targets pigmentation through a fundamentally different pathway than acid-based or standard brightening approaches.Tranexamic Acid 5% blocks the hormonal and UV-triggered signals that cause pigmentation in the first place. Azelaic Acid 3% provides anti-inflammatory and pigment-reducing dual action. Niacinamide 10% stops pigment transfer from pigment-producing cells to surrounding skin cells. Hyaluronic Acid 1% maintains barrier hydration. Total active load: 19%.Addresses hormonal and vascular components of melasma that conventional agents cannot reach. ~75 sessions per 30ml bottle.

Indications
Melasma Maintenance
Melasma Maintenance
Post-Peel Care
Post-Peel Care
Discoloration
Discoloration
Vascular Pigmentation
Vascular Pigmentation
Active Agents
Tranexamic Acid
Azelaic Acid
Niacinamide
Hyaluronic Acid
Volume
30ml
Sessions/Jar
~75
Peel Depth
Superficial
Fitzpatrick
Professional use
Category
Serum
Shelf Life
24 months
Dispatch
Same Day
Min Order
1 unit
Same-Day Dispatch
Zero Minimum
GMP Certified
Prodermic Certified
Prodermic® Certified Seller
Only purchase Prodermic® products from certified partners and authorized distributors to ensure genuine formulations.
Formulation Technology

Tranexamic Anti-Pigment Architecture™

TANH-4Complex

TANH-4 Complex — Tranexamic Acid 5% with azelaic acid anti-inflammatory action, niacinamide pigment-transfer blocking, and hyaluronic acid barrier support.Tranexamic Acid 5% blocks the UV-triggered and hormonal signaling cascade that tells pigment cells to produce melanin, interrupting the cause of pigmentation at its source. Azelaic Acid 3% provides anti-inflammatory action while selectively targeting overactive pigment cells. Niacinamide 10% stops pigment transfer to prevent visible discoloration even when melanin is produced. Hyaluronic Acid 1% ensures barrier health during continuous depigmentation.A completely different approach to melasma — addresses the root triggers, not just the symptoms.

Application Protocol

Recommended sequence for prodermic TXA.sr. Frequency: Daily (AM/PM).

Step 01
Cleanse skin thoroughly
Step 02
Apply to pigmented areas
Step 03
Massage gently
Step 04
Follow with moisturizer and SPF
Mechanism of Action
Tranexamic Acid
Plasmin inhibitor blocking UV-induced plasminogen activator, prevents keratinocyte-melanocyte signaling. Reduces vascular component of melasma.
Tranexamic Acid 5%
Lead Active
19%
Total Concentration
N/A (Serum)
Peel Depth
None (Daily Use)
Aggression
Ideal Patient Profile

Hormonal melasma, recurrent melasma despite peel treatment, patients on hormonal medication, premium upsell for severe melasma cases

Contraindications